Slingshot members are tracking this event:

Gilead (GILD) Expects to Release Futility Analysis in Q3 2017 From Phase 3 Trial Evaluating GS-5745 in Gastric Cancer

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
May 30, 2017
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Futility Analysis, Phase 3, Gs-5745, Gastric Cancer